RNLXY
Renalytix plc
0.00 (0.00%)4.17USD0成交股數–市值–本益比(近四季)–股價營收比+13.7%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 6 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。外國發行人(20-F)通常只申報半年或年度,逐季會有缺。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 | 23Q1 | 22Q3 | 22Q2 | 22Q1 | 21Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 522K-119% | 535K-26% | 709K-41% | 459K-53% | −2.8M-443% | 724K-14% | 1.2M+147% | 969K | 812K | 845K | 482K | – |
| 營業成本 | 422K | 601K | 480K | 502K | 673K | 603K | 711K | 696K | 685K | 492K | 227K | – |
| 毛利 | 100K-165% | −66K-155% | 229K-52% | −43K-116% | −155K-222% | 121K-66% | 481K+89% | 273K | 127K | 353K | 255K | – |
| 毛利率 | 19.2% | -12.3% | 32.3% | -9.4% | 5.6% | 16.7% | 40.4% | 28.2% | 15.6% | 41.8% | 52.9% | – |
| 研發費用 | 921K | 2.2M | 3.2M | 2.8M | 3.3M | 3.9M | 3.3M | 3.8M | 3.9M | 4.1M | 4.0M | – |
| 銷售管理費用 | 3.3M | 3.9M | 5.3M | 6.1M | 6.5M | 7.1M | 6.8M | 8.3M | 10.8M | 10.1M | 8.1M | – |
| 營業利益 | −4.1M-59% | −6.6M-40% | −8.6M-10% | −8.9M-24% | −9.9M-32% | −10.9M-21% | −9.6M-18% | −11.7M | −14.5M | −13.8M | −11.8M | – |
| 營業利益率 | -784.1% | -1,224.9% | -1,218.8% | -1,936.6% | 356.7% | -1,507.9% | -809.4% | -1,209.7% | -1,790.3% | -1,631.0% | -2,451.0% | – |
| 稅後淨利 | −4.7M-57% | −7.7M-36% | −8.5M-19% | −10.2M-15% | −11.1M-24% | −12.1M-21% | −10.4M+3% | −12.0M+22% | −14.7M | −15.3M | −10.1M | −9.8M |
| 淨利率 | -905.7% | -1,447.3% | -1,196.8% | -2,212.2% | 398.7% | -1,672.1% | -876.2% | -1,233.5% | -1,809.7% | -1,813.3% | -2,096.7% | – |
| 稀釋 EPS | -0.04-64% | -0.08-43% | -0.09-36% | -0.11-31% | -0.11-45% | -0.14-33% | -0.140% | -0.16 | -0.20 | -0.21 | -0.14 | – |
| 稀釋股數 | 106M | 97.7M | 97.3M | 94.8M | 82.2M | 85.6M | 74.9M | 74.8M | 72.3M | 72.3M | 72.2M | 71.5M |
資產負債表 期末餘額
| 科目 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 | 23Q1 | 22Q3 | 22Q2 | 22Q1 | 21Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 909K | 4.7M | 5.6M | 13.9M | 24.7M | 33.0M | 23.8M | 31.0M | 32.4M | 39.9M | – | 65.1M |
| 應收帳款 | 902K | 554K | 1.4M | 1.0M | 776K | 747K | 820K | 1.2M | 1.0M | 823K | – | 594K |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 4.8M | 8.8M | 11.3M | 19.5M | 30.6M | 39.8M | 30.7M | 38.7M | 44.5M | 54.4M | – | 78.6M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 16.1M | 19.9M | 19.2M | 21.0M | 23.7M | 21.7M | 21.8M | 19.9M | 15.1M | 8.6M | – | 7.1M |
| 股東權益 | −11.3M | −11.1M | −8.0M | −1.5M | 7.0M | 18.1M | 8.9M | 18.8M | 29.4M | 45.8M | 60.0M | 71.5M |
| 負債比 | 336.1% | 226.7% | 170.6% | 107.6% | 77.3% | 54.5% | 71.0% | 51.3% | 33.8% | 15.7% | – | 9.1% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 | 23Q1 | 22Q3 | 22Q2 | 22Q1 | 21Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | −3.8M | – | – | −9.5M+34% | – | – | – | −7.1M | – | – | −10.5M | – |
| 資本支出 | – | – | – | – | – | – | – | 0 | – | – | 224K | – |
| 自由現金流 | – | – | – | – | – | – | – | −7.1M | – | – | −10.7M | – |
| 折舊攤銷 | 60K | – | – | 127K | – | – | – | 130K | – | – | 119K | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | 8.8M | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | -734.7% | – | – | -2,222.8% | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2024 | 2.3M | +2189.0% | −33.5M | -1,461.6% | -0.31 | – |
| FY2023 | 100K | -96.6% | −45.6M | -45,607.0% | -0.55 | −34.1M |
| FY2022 | 3.0M | +99.2% | −45.3M | -1,524.4% | -0.67 | −46.5M |
| FY2021 | 1.5M | – | −35.3M | -2,370.0% | -0.49 | −29.2M |
| FY2020 | 0 | – | −9.8M | –% | -0.17 | −10.3M |
| FY2019 | – | – | −42.3M | –% | -0.99 | −6.5M |